Baluch Khoso

SEC Form 4 insider trading activity

Baluch Khoso has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.

On the most recent filing, Baluch Khoso is listed as Director at Processa Pharmaceuticals, Inc. Inside the rolling window, Baluch Khoso reported 1 open-market purchase totaling $6K in PCSA and no open-market sales.

Companies traded

Other insiders at PCSA

Insider Buying

$6K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PCSA
Baluch Khoso
Purchase$6KApr 1SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Baluch Khoso made?

Baluch Khoso has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.

Which companies does Baluch Khoso trade?

Baluch Khoso has filed SEC Form 4 disclosures for 1 company, including PCSA.

When was Baluch Khoso's most recent SEC Form 4 filing?

Baluch Khoso's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.

What is Baluch Khoso's total buy and sell value in the current window?

Inside the rolling retention window, Baluch Khoso bought $6K and sold $0 based on SEC Form 4 filings.

What was Baluch Khoso's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,269 PCSA shares on 2026-03-31, worth $6K, per SEC Form 4 filings.